CD34+ Hematopoietic Stem Cell Counts in Alzheimer's Disease: A Meta-Analysis

Area of Science:

• Neuroscience
• Hematology
• Immunology

Background:

• Alzheimer's disease (AD) is a progressive neurodegenerative disorder.
• CD34+ cells are hematopoietic stem cells crucial for blood cell regeneration.
• The role of stem cells in AD pathogenesis remains an active area of investigation.

Purpose of the Study:

• To conduct a meta-analysis assessing the quantity of CD34+ hematopoietic stem cells in individuals with Alzheimer's disease (AD).
• To compare CD34+ cell counts between AD patients and healthy controls.

Main Methods:

• Systematic literature search for observational and interventional studies reporting CD34+ cell counts in AD patients.
• Meta-analysis using common and random effects models to calculate standardized mean differences (SMDs).
• Assessment of heterogeneity (I², p-value) and risk of bias (Newcastle-Ottawa Scale, ROBINS-I).

Main Results:

• Five studies with 271 participants (139 AD patients, 132 controls) were included.
• A common effects model suggested a moderate increase in CD34+ cells in AD patients (SMD=0.2964).
• A random effects model showed a non-significant increase (SMD=0.2326), with substantial heterogeneity observed (I²=87.1%, p<0.0001).

Conclusions:

• Preliminary findings suggest potentially higher circulating CD34+ cell counts in Alzheimer's disease patients compared to controls.
• Significant heterogeneity and potential biases among the included studies limit the certainty of these conclusions.
• Further high-quality research is warranted to clarify the role of CD34+ cells in Alzheimer's disease.